Miller School of Medicine: Paradigm Shift for Hard-to-Treat Sarcomas
October 11, 2019
October 11, 2019
MIAMI, Florida, Oct. 11 [TNSmedicalresearch] -- The University of Miami's Miller School of Medicine issued the following news:
Two recent studies by Sylvester Comprehensive Cancer Center researchers are the first to suggest that immunotherapy plays a key role in treating sarcomas, namely angiosarcoma and alveolar soft-part sarcoma.
The findings could change the treatment paradigm for sarcoma types that have few if any treatment options, according to an author on both st . . .
Two recent studies by Sylvester Comprehensive Cancer Center researchers are the first to suggest that immunotherapy plays a key role in treating sarcomas, namely angiosarcoma and alveolar soft-part sarcoma.
The findings could change the treatment paradigm for sarcoma types that have few if any treatment options, according to an author on both st . . .